Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • alexhaj
    Junior Member
    • Mar 2015
    • 6

    llumina no longer services instruments purchased through third parties

    Greetings

    Dear fellow seqers

    I was considering a used HiSeq2500 V3 purchase. One of my requirements was that it be upgradeable to V4. I checked online and found instruments with serial above D00101 were upgradeable.

    I wanted to confirm with our local Illumina field service engineer (who is a fantastic engineer by the way). He put me through to Illumina sales and here is the response I got:
    Hi ----

    I was speaking with ---- earlier regarding this potential purchase and I asked him to forward your email so that I could reply. Unfortunately, Illumina no longer services instruments purchased through third parties and the license and rights of use are non-transferrable. I think this was implemented several months ago. I apologize for the inconvenience and sorry for being the bearer of bad news, but I wanted to make sure you were aware of this before you moved forward with the purchase so you could take all the variables into consideration.

    I’d be happy to forward this to management if you would like more details on this policy or would like to discuss this further.

    Sincerely,
    ----

    What kind of service do you think is being referred to here? Just upgrades? Maybe repairs as well? Am I not even allowed to legally use a third-party purchased machine? Is this only for machines purchased after this so-called new policy? I couldn't find any kind of press release regarding this seemingly major shift, maybe I'm just not looking hard enough.


    Does this come as a shock to anyone? How do you feel about this?

    Looking forward to the community's take.
    Last edited by alexhaj; 12-16-2015, 04:15 AM.
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    Does it also mean that they can potentially refuse to sell you reagents (since the wording above says "license and rights of use are non-transferable")? Did you ask?

    Comment

    • alexhaj
      Junior Member
      • Mar 2015
      • 6

      #3
      No I haven't asked. Frankly I don't know whether I should ask. If we already had a preowned MiSeq it would seem very strange that they have been servicing that unit and providing reagents for that unit for the past year despite knowing how we acquired it, IF we acquired it.

      To my thinking it seems that Illumina might say anything to discourage the purchase of a pre-owned machine but once you already have it why would they turn down that lucrative revenue stream.

      Comment

      • pmiguel
        Senior Member
        • Aug 2008
        • 2328

        #4
        I didn't think there was any hardware required for V4. Either your HiSeq was capable of doing it (camera?) or not.

        --
        Phillip

        Comment

        • alexhaj
          Junior Member
          • Mar 2015
          • 6

          #5
          You still have to do a software upgrade and firmware upgrade for the FPGA at a cost of about $15,000!

          Comment

          • GenoMax
            Senior Member
            • Feb 2008
            • 7142

            #6
            This would be a big gamble then. They may sell you the reagents but if they refuse to fix a broken machine/provide software updates/supply parts then you would be up the creek.

            Perhaps the company that sells you the machine can be made contractually obligated to take the sequencer back if Illumina refuses to service it within a year or some mutually agreeable period of time.

            Comment

            • HESmith
              Senior Member
              • Oct 2009
              • 512

              #7
              Originally posted by GenoMax View Post
              This would be a big gamble then. They may sell you the reagents but if they refuse to fix a broken machine/provide software updates/supply parts then you would be up the creek.

              Perhaps the company that sells you the machine can be made contractually obligated to take the sequencer back if Illumina refuses to service it within a year or some mutually agreeable period of time.
              Has anyone ever run a HiSeq for a year without needing service? Ours is pretty robust, according to our FAS, but we still see him every three-four months.

              Comment

              • dannyhi321
                Member
                • Jul 2014
                • 51

                #8
                you might be interested in tis thread.. not that its third party - i own the machines from new.. but a picture emerges ...

                Bridged amplification & clustering followed by sequencing by synthesis. (Genome Analyzer / HiSeq / MiSeq)
                Last edited by dannyhi321; 02-20-2016, 11:50 AM.

                Comment

                • boothie
                  Junior Member
                  • Mar 2018
                  • 8

                  #9
                  alexhaj - can you send me the full email from Illumina via private message?

                  Comment

                  • alexhaj
                    Junior Member
                    • Mar 2015
                    • 6

                    #10
                    Hi I don't have it as it was sent to someone in procurement. Turns out though that it's all negotiations. They said if we bought a new NextSeq then they would be willing to support us on a used HiSeq should we ever get one.

                    although they did stop selling us nextseq reagents until we bought a new machine from them.

                    Comment

                    • boothie
                      Junior Member
                      • Mar 2018
                      • 8

                      #11
                      Hi alex. Can you DM me more information about them not selling reagents?

                      Comment

                      Latest Articles

                      Collapse

                      • SEQadmin2
                        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                        by SEQadmin2


                        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                        The systematic characterization of the human proteome has
                        ...
                        07-20-2026, 11:48 AM
                      • SEQadmin2
                        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                        by SEQadmin2



                        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                        ...
                        07-09-2026, 11:10 AM
                      • SEQadmin2
                        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                        by SEQadmin2



                        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                        07-08-2026, 05:17 AM

                      ad_right_rmr

                      Collapse

                      News

                      Collapse

                      Topics Statistics Last Post
                      Started by SEQadmin2, 07-24-2026, 12:17 PM
                      0 responses
                      16 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-23-2026, 11:41 AM
                      0 responses
                      18 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-20-2026, 11:10 AM
                      0 responses
                      24 views
                      0 reactions
                      Last Post SEQadmin2  
                      Started by SEQadmin2, 07-13-2026, 10:26 AM
                      0 responses
                      37 views
                      0 reactions
                      Last Post SEQadmin2  
                      Working...